Tetraethyl orthosilicate

We are Tetraethyl orthosilicate CAS:78-10-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Tetraethyl orthosilicate
CAS.NO:78-10-4
Synonyms:ethyl orthosilicate; tetraethyl ortosilicate; tetra-ethyl orthosilicate;
Molecular Formula:C8H20O4Si
Molecular Weight:208.32700
 
Physical and Chemical Properties:
Density:0.94;
Melting point:-77oC;
Boiling point:168oC;
Flash point:46oC;
Index of Refraction:1.382;
 
Specification:
Appearance:Colorless transparent liquid
Purity(GC):≥99.0%
 
Packing:190 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It may be used as an inorganic binder for refractory fillers and pigments, like precision investment castings.
It may be used as a second backup casting coating. It cures faster than colloidal silica system.
It may be hydrolyzed to form silicon dioxide(silica).
It may be used as a binder in zinc-rich (corrosion resistant) coating.
It may be used as a starting material for sol-gel process.
It may be used as a crosslinking agent for silicone sealant.
It may be used as a drying agent in sealing compositions.
It may be used as a chemical intermediate

Tetraethyl orthosilicate


Related News: In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.3,4-Difluoronitrobenzene CAS:369-34-6 Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.141106-52-7 “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.Piridina-3-sulfonil cloruro CAS:16133-25-8 “Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.”The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.

Related Products
Product Name
2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate View Details
Tripeptide-32 View Details
4-(1-Acetylpiperazin-4-yl)Phenol View Details
S-methyl thioacetate manufacturer 3-Cyclopropylmethoxy-4-difluoromethoxybenzoic Acid manufacturer Tetrachlorosilane manufacturer Acetoxyacetyl chloride manufacturer 2-Chlorobenzoyl chloride manufacturer